Nurse Practitioner, Family · Glendale, CA
NPI
1972909406
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1030 S Glendale Ave Ste 404
Glendale, CA, 91205
Phone (818) 240-9911
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
6,500 services
Medicare patients, 2024
375
Average age 75
Drug cost, 2024
$3.1M
23,738 prescriptions
Company payments, 2025
$474
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Armen Avetisyan was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 2,224 times for 113 patients. In total Armen Avetisyan billed 6,500 services in 69 codes, and Medicare paid $129K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-16.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2,224 | 113 | $0.77 | $1,723 |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 1,070 | 18 | $4.98 | $5,333 |
| 99214 Office E&M - Established | Office | 545 | 294 | $90.07 | $49K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 404 | 83 | $0.09 | $35.85 |
| 99213 Office E&M - Established | Office | 403 | 255 | $63.82 | $26K |
| 93000 Electrocardiogram | Office | 325 | 234 | $10.24 | $3,329 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 321 | 169 | $22.81 | $7,322 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 117 | 33 | $0.45 | $52.26 |
| 69210 Other Organ Systems | Office | 115 | 95 | $34.06 | $3,917 |
| 82950 Clinical Chemistry | Office | 93 | 60 | $4.65 | $432 |
| 94010 Pulmonary Function Testing | Office | 91 | 80 | $20.19 | $1,837 |
| 20553 Musculoskeletal | Office | 76 | 68 | $43.05 | $3,272 |
| 94664 E&M - Miscellaneous | Office | 61 | 53 | $13.61 | $830 |
| 96372 Injection Administration | Office | 55 | 40 | $10.10 | $555 |
| 92567 Test - Miscellaneous | Office | 43 | 42 | $11.46 | $493 |
By year: 2023 $3,190 for 116 services; 2024 $129K for 6,500 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82950 Clinical Chemistry | 93 | 60 | $4.65 | $432 |
Medicare prescription drug claims, 2024
In 2024, the drug Armen Avetisyan prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,089 prescriptions and refills. In total Armen Avetisyan wrote 23,738 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,089 | 1,290 | 143 | $2,789 |
| Gabapentin Generic | 722 | 761 | 97 | $2,275 |
| Amlodipine Besylate Generic | 714 | 831 | 96 | $691 |
| Omeprazole Generic | 677 | 802 | 103 | $2,374 |
| Ibuprofen Generic | 508 | 533 | 85 | $3,164 |
| Metformin Hcl Generic | 470 | 520 | 65 | $1,025 |
| Meclizine Hcl Generic | 469 | 495 | 63 | $3,250 |
| Diclofenac Sodium Generic | 464 | 577 | 85 | $199K |
| Tamsulosin Hcl Generic | 457 | 523 | 59 | $2,015 |
| Levothyroxine Sodium Generic | 426 | 532 | 50 | $3,833 |
| Losartan Potassium Generic | 410 | 452 | 55 | $1,049 |
| Vascepa Icosapent Ethyl | 402 | 437 | 55 | $135K |
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 341 | 433 | 45 | $500K |
| Rosuvastatin Calcium Generic | 340 | 380 | 51 | $1,471 |
| Hydrochlorothiazide Generic | 338 | 381 | 43 | $254 |
Brand drugs: 3,591 claims; generic drugs: 19,758 claims; opioid claims: 259.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Armen Avetisyan $474 ($474 in general payments such as food, travel and fees) from 9 companies. The largest payer was Boston Scientific Corporation with $84.72.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.